Biocompatible component

Patent metadata

Field	Value
Publication number	US-10052404-B2
Application number	US-201213468243-A
Country	US
Kind code	B2
Filing date	May 10, 2012
Priority date	May 11, 2011
Publication date	Aug 21, 2018
Grant date	Aug 21, 2018

Abstract

The invention provides a biocompatible component having a surface intended for contact with living tissue, wherein the surface comprises particles of metal oxide, said particles having an average particle size of less than 100 nm.

First claim

The invention claimed is:

1. A biocompatible component having a surface intended for contact with living tissue, wherein the surface comprises particles of metal oxide, said particles having an average particle size of less than 25 nm, and wherein said particles form at least one layer, each layer having a thickness in the range of from 8 nm to about 1 μm; wherein the particles of metal oxide comprise particles of titanium dioxide and one or more particles selected from the group consisting of an oxide of zirconium, hafnium, vanadium, niobium, tantalum, cobalt and iridium and wherein the predominant form of said titanium dioxide is anatase and wherein the particles have a particle size distribution of up to 40%.

2. The biocompatible component according to claim 1 , wherein the particle size distribution, taken as the ratio between the full width at half maximum (FWHM) divided by the mean particle size, is obtained by electrospray-scanning mobility particle sizer (ES-SMPS).

3. The biocompatible component according to claim 1 , wherein said particles have a spherical shape.

4. The biocompatible component according to claim 1 , wherein the metal oxide is at least partly crystalline.

5. The biocompatible component according to claim 1 , wherein each layer of said at least one layer has a thickness in the range of from 50 nm to 500 nm.

6. The biocompatible component according to claim 1 , wherein said at least one layer is a monolayer of said particles.

7. The biocompatible component according to claim 1 , wherein said at least one layer is a continuous layer of said particles.

8. The biocompatible component according to claim 1 , wherein said at least one layer completely covers said surface.

9. The biocompatible component according to claim 1 , wherein said particles are homogeneously distributed throughout said at least one layer.

10. The biocompatible component according to claim 1 , wherein said particles are non-sintered.

11. The biocompatible component according to claim 1 , wherein at least some of said particles are sintered particles.

12. The biocompatible component according to claim 1 , wherein said surface has an electrochemically relative active surface area (A aa ) of at least 1.5, compared to a corresponding biocompatible component which lacks said particles and has a surface covered by native metal oxide.

13. The biocompatible component according to claim 1 , wherein said biocompatible component comprises a substrate having said surface, which substrate comprises a metallic material.

14. The biocompatible component according to claim 13 , wherein said metallic material is selected from titanium, zirconium, hafnium, vanadium, niobium, tantalum, cobalt and iridium, and alloys thereof.

15. The biocompatible component according to claim 1 , wherein a part of the substrate that is in contact with said particles comprises titanium oxide.

16. The biocompatible component according to claim 1 , wherein said biocompatible component is intended for implantation into living tissue.

17. The biocompatible component according to claim 16 which is a dental implant, preferably a dental fixture.

18. The biocompatible component according to claim 16 , which is an orthopedic implant.

19. The biocompatible component according to claim 1 , wherein nucleation of hydroxyapatite crystals forms on the surface of said biocompatible component within 12 hours when immersed in simulated body fluid.

20. A method of producing a biocompatible component, comprising the steps of:
a) providing a substrate having a surface intended for contact with living tissue;
b) providing a dispersion of particles of metal oxide in a solvent, which particles have an average particle size of less than 25 nm; and
c) applying said dispersion of particles onto the surface of said substrate;
wherein said particles form at least one layer, each layer having a thickness in the range of from 8 nm to about 1 μm; wherein the particles of metal oxide comprise particles of titanium dioxide and one or more particles selected from the group consisting of an oxide of zirconium, hafnium, vanadium, niobium, tantalum, cobalt and iridium and wherein the predominant form of said titanium dioxide is anatase; and wherein the particles have a particle size distribution of up to 40%.

21. The method according to claim 20 , wherein said particles are completely dispersed in said solvent.

22. The method according to claim 20 , wherein said dispersion is applied by spin coating.

23. The method according to claim 20 , further comprising the step of: d) allowing said solvent to evaporate.

24. The method according to claim 20 , further comprising the step of: e) sintering said particles.

25. The method according to claim 20 , wherein said dispersion of particles of metal oxide is provided by: b-i) performing controlled hydrolysis of TiCl 4 in water to obtain a colloid dispersion; and b-ii) performing dialysis of said colloidal dispersion.

26. The method according to claim 20 , wherein the surface of the substrate comprises a native oxide.

27. The method according to claim 20 , wherein the surface of the substrate body prior to step c) has been subjected to a roughening surface treatment, such as abrasive blasting and/or chemical etching.

28. The method according to claim 20 , wherein said substrate body is turned.

29. The method according to claim 20 , wherein the surface of said substrate body is polished.

30. The method according to claim 1 , wherein said particles are packed together on the surface such that when said at least one layer results in a monolayer, the monolayer has an inherent porosity from at least 0.225*R with R being the average radius of the particles.

31. The method according to claim 1 , wherein said particles are packed together on the surface such that when said at least one layer results in multilayers, the multilayers have an inherent porosity from at least 0.732*R with R being the average radius of the particles.

32. The method according to claim 20 , wherein said particles are packed together on the surface such that when said at least one layer results in a monolayer, the monolayer has an inherent porosity from at least 0.225*R with R being the average radius of the particles.

33. The method according to claim 1 , wherein said particles are packed together on the surface such that when said at least one layer results in multilayers, the multilayers have an inherent porosity from at least 0.732*R with R being the average radius of the particles.

Assignees

• Ahlberg Elisabet
• Mattisson Ingela
• Loeberg Johanna
• Dentsply Sirona Inc

Inventors

• Ahlberg Elisabet
• Mattisson Ingela
• Löberg Johanna

Classifications

• Y10T428/2982

  Particulate matter [e.g., sphere, flake, etc.] · CPC title

• Y10T428/25

  Web or sheet containing structurally defined element or component and including a second component containing structurally defined particles · CPC title

• A61L27/06

  Titanium or titanium alloys · CPC title

• A61L27/04 Primary

  Metals or alloys · CPC title

• A61L27/00 Primary

  Materials for {grafts or} prostheses or for coating {grafts or} prostheses (dental prostheses A61C13/00; shape or structure of prostheses A61F2/00; use of preparations for artificial teeth A61K6/80; artificial kidneys A61M1/14) · CPC title